Skip to main content
Top
Published in: Journal of Public Health 5/2007

01-10-2007 | Original Article

Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE project

Authors: Peter E. H. Schwarz, Ulrike Gruhl, Stefan R. Bornstein, Rüdiger Landgraf, Michael Hall, Jaakko Tuomilehto

Published in: Journal of Public Health | Issue 5/2007

Login to get access

Abstract

Background

The dramatic increase of type 2 diabetes, particularly in younger people, has developed into a major public health concern of the European Union (EU). Several studies have demonstrated that prevention programmes can significantly reduce the risk of developing diabetes. At the EU level, there is a clear consensus that action is needed now to develop targeted prevention management programmes for type 2 diabetes. Currently several prevention management concepts exist in various European countries which can be implemented in clinical practice. Nevertheless, EU-wide strategies are still lacking. Therefore, initiated by the Technical University Dresden, the IMAGE project was submitted to the European Commission under the call for proposals 2006 for the programme of community action in the field of public health (2003–2008) and recommended for co-funding as one of the largest in the public health sector.

Methods

IMAGE stands for “Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention”. Its general objective is to improve the ability of EU countries to prevent type 2 diabetes in Europe. Within the project, four specific objectives will be developed and implemented into clinical practice: (1) joint European guidelines, (2) a European curriculum for the training of prevention managers, (3) European standards for quality control of diabetes prevention programmes, and (4) a European e-health training portal for prevention managers.

Results

By now, 32 partners from 13 EU member states plus partners from Serbia-Montenegro, the Ukraine and Israel are involved in the project. The project duration is 3 years, starting in May 2007. The partners who are involved in the IMAGE project, building a consortium of expertise, will work in seven work packages to achieve the project’s objectives.

Conclusion

The development of competent education programmes, as well as the establishment of quality standards for the primary prevention of type 2 diabetes, will significantly enhance the ability of healthcare professionals to respond swiftly to the drastic increase of type 2 diabetes and its burden to society. Implementing the project achievements will be of major importance in both the prevention of diabetes and the promotion of health through addressing health determinants across all policies and activities in Europe.
Literature
go back to reference Benterbusch R, Eberhard C et al (2007) Sachsen. Gesundheitsziele im Föderalismus-Programme der Länder und des Bundes. GfV u-g e V Berlin, Schriftenreihe der GVG 55(1):191 Benterbusch R, Eberhard C et al (2007) Sachsen. Gesundheitsziele im Föderalismus-Programme der Länder und des Bundes. GfV u-g e V Berlin, Schriftenreihe der GVG 55(1):191
go back to reference BMGF (2006) EU Conference on Prevention of Type 2 Diabetes. Federal Ministry of Health and Women, Vienna BMGF (2006) EU Conference on Prevention of Type 2 Diabetes. Federal Ministry of Health and Women, Vienna
go back to reference Chiasson JL, Josse RG et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359(9323):2072–2077PubMedCrossRef Chiasson JL, Josse RG et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359(9323):2072–2077PubMedCrossRef
go back to reference Knowler WC, Barrett-Connor E et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403PubMedCrossRef Knowler WC, Barrett-Connor E et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403PubMedCrossRef
go back to reference Nestle M (2005) Preventing childhood diabetes: the need for public health intervention. Am J Public Health 95(9):1497–1499PubMedCrossRef Nestle M (2005) Preventing childhood diabetes: the need for public health intervention. Am J Public Health 95(9):1497–1499PubMedCrossRef
go back to reference Pan XR, Li GW et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544PubMedCrossRef Pan XR, Li GW et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544PubMedCrossRef
go back to reference Ramachandran A, Snehalatha C et al (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289–297PubMedCrossRef Ramachandran A, Snehalatha C et al (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289–297PubMedCrossRef
go back to reference Roubideaux Y, Buchwald D et al (2004) Measuring the quality of diabetes care for older American Indians and Alaska natives. Am J Public Health 94(1):60–65PubMedCrossRef Roubideaux Y, Buchwald D et al (2004) Measuring the quality of diabetes care for older American Indians and Alaska natives. Am J Public Health 94(1):60–65PubMedCrossRef
go back to reference Schwarz PE, Bornstein SR (2006) Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res 38(5):359PubMedCrossRef Schwarz PE, Bornstein SR (2006) Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res 38(5):359PubMedCrossRef
go back to reference Schwarz PE, Schwarz J et al (2006) Diabetes prevention-from physiology to implementation. Horm Metab Res 38(7):460–464PubMedCrossRef Schwarz PE, Schwarz J et al (2006) Diabetes prevention-from physiology to implementation. Horm Metab Res 38(7):460–464PubMedCrossRef
go back to reference Schwarz PE, Gruhl U et al (2007a) Prevention of diabetes mellitus: the future of German diabetology. Hamostaseologie 27(1):13–21PubMed Schwarz PE, Gruhl U et al (2007a) Prevention of diabetes mellitus: the future of German diabetology. Hamostaseologie 27(1):13–21PubMed
go back to reference Schwarz PE, Schwarz J et al (2007b) Development of a diabetes prevention management program for clinical practice. Public Health Rep 122(2):258–263PubMed Schwarz PE, Schwarz J et al (2007b) Development of a diabetes prevention management program for clinical practice. Public Health Rep 122(2):258–263PubMed
go back to reference Schwarz P, Schwarz J et al (2005) Prevention of type 2 diabetes: what challenges do we have to address? J Public Health 13(2):296–303 Schwarz P, Schwarz J et al (2005) Prevention of type 2 diabetes: what challenges do we have to address? J Public Health 13(2):296–303
go back to reference Snitker S, Watanabe RM et al (2004) Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. Diabetes Care 27(6):1365–1368PubMedCrossRef Snitker S, Watanabe RM et al (2004) Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. Diabetes Care 27(6):1365–1368PubMedCrossRef
go back to reference Torgerson JS, Hauptman J et al (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(1):155–161PubMedCrossRef Torgerson JS, Hauptman J et al (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(1):155–161PubMedCrossRef
go back to reference Tuomilehto J, Lindstrom J et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350PubMedCrossRef Tuomilehto J, Lindstrom J et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350PubMedCrossRef
go back to reference Valensi P, Schwarz PE et al (2005) Pre-diabetes essential action: a European perspective. Diabetes Metab 31(6):606–620PubMedCrossRef Valensi P, Schwarz PE et al (2005) Pre-diabetes essential action: a European perspective. Diabetes Metab 31(6):606–620PubMedCrossRef
Metadata
Title
Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE project
Authors
Peter E. H. Schwarz
Ulrike Gruhl
Stefan R. Bornstein
Rüdiger Landgraf
Michael Hall
Jaakko Tuomilehto
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Journal of Public Health / Issue 5/2007
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-007-0145-x

Other articles of this Issue 5/2007

Journal of Public Health 5/2007 Go to the issue

Editorial

Editorial